These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toll-like receptor 4 is up-regulated by mTOR activation during THP-1 macrophage foam cells formation. Yu M; Kang X; Xue H; Yin H Acta Biochim Biophys Sin (Shanghai); 2011 Dec; 43(12):940-7. PubMed ID: 22015781 [TBL] [Abstract][Full Text] [Related]
3. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects. Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457 [TBL] [Abstract][Full Text] [Related]
4. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation. Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144 [TBL] [Abstract][Full Text] [Related]
5. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration. Razmara M; Monazzam A; Skogseid B Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764 [TBL] [Abstract][Full Text] [Related]
6. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes. Weinberg MA Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392 [TBL] [Abstract][Full Text] [Related]
7. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692 [TBL] [Abstract][Full Text] [Related]
8. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons. Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937 [TBL] [Abstract][Full Text] [Related]
9. A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS. Iskandar K; Foo J; Liew AQX; Zhu H; Raman D; Hirpara JL; Leong YY; Babak MV; Kirsanova AA; Armand AS; Oury F; Bellot G; Pervaiz S Autophagy; 2024 Jun; 20(6):1418-1441. PubMed ID: 38261660 [TBL] [Abstract][Full Text] [Related]
10. PI3K/Akt promotes feedforward mTORC2 activation through IKKα. Dan HC; Antonia RJ; Baldwin AS Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448 [TBL] [Abstract][Full Text] [Related]
11. The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling. Merhi A; Delrée P; Marini AM Sci Rep; 2017 Mar; 7():44602. PubMed ID: 28303961 [TBL] [Abstract][Full Text] [Related]
12. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells. Zheng B; Wang J; Tang L; Shi J; Zhu D Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249 [TBL] [Abstract][Full Text] [Related]
13. Liraglutide Improves Endothelial Function via the mTOR Signaling Pathway. Wu H; Xiao C; Zhao Y; Yin H; Yu M J Diabetes Res; 2021; 2021():2936667. PubMed ID: 34447854 [TBL] [Abstract][Full Text] [Related]
14. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2. Tsutsumi K; Nohara A; Tanaka T; Murano M; Miyagaki Y; Ohta Y Sci Rep; 2023 Dec; 13(1):20956. PubMed ID: 38065968 [TBL] [Abstract][Full Text] [Related]
15. Calcium-independent phospholipase A2beta-Akt signaling is involved in lipopolysaccharide-induced NADPH oxidase 1 expression and foam cell formation. Lee SH; Park DW; Park SC; Park YK; Hong SY; Kim JR; Lee CH; Baek SH J Immunol; 2009 Dec; 183(11):7497-504. PubMed ID: 19917703 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Tian L; Luo N; Zhu X; Chung BH; Garvey WT; Fu Y Atherosclerosis; 2012 Mar; 221(1):66-75. PubMed ID: 22227293 [TBL] [Abstract][Full Text] [Related]
17. Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition. Matsubara S; Tsukasa K; Kuwahata T; Takao S Hum Cell; 2020 Oct; 33(4):1197-1203. PubMed ID: 32851605 [TBL] [Abstract][Full Text] [Related]
18. The underlying mechanism of proinflammatory NF-κB activation by the mTORC2/Akt/IKKα pathway during skin aging. Choi YJ; Moon KM; Chung KW; Jeong JW; Park D; Kim DH; Yu BP; Chung HY Oncotarget; 2016 Aug; 7(33):52685-52694. PubMed ID: 27486771 [TBL] [Abstract][Full Text] [Related]
19. TIS21 Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317 [TBL] [Abstract][Full Text] [Related]
20. DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells. Cheng M; Lv X; Zhang C; Du W; Liu Y; Zhu L; Hao J Neurochem Res; 2018 Nov; 43(11):2141-2154. PubMed ID: 30229399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]